Deulumateperone

Last updated

Deulumateperone
Deulumateperone.svg
Clinical data
Other namesLumateperone deuterated; Deuterated lumateperone; ITI-1284; ITI1284; ITI-1284-ODT-SL
Routes of
administration 		Sublingual (orally disintegrating tablet) [1]
Drug class Atypical antipsychotic
Identifiers
  • 1-(4-fluorophenyl)-4-[(6bR,10aS)-3-methyl-2,3,6b,9,10,10a-(2-2H)hexahydro(2-2H)-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]butan-1-one
CAS Number
Chemical and physical data
Formula C24H26D2FN3O
Molar mass 395.518 g·mol−1
3D model (JSmol)
  • CN1C([2H])([2H])CN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
  • InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1/i14D2
  • Key:HOIIHACBCFLJET-FTHFLAHXSA-N

Deulumateperone (INN Tooltip International Nonproprietary Name; developmental code name ITI-1284) is an experimental antipsychotic and deuterated analogue of lumateperone which is under development as a sublingually administered orally disintegrating tablet (ODT) for the treatment of psychotic disorders, agitation, and generalized anxiety disorder. [2] [3] [4] [1] No recent development has been reported for treatment of depressive disorders, behavioral disorders, and dementia. [2] It is being developed by Intra-Cellular Therapies. [2] [3] [1] As of January 2025, it has reached phase 2 clinical trials. [2] [3]

See also

References

  1. 1 2 3 Oguma T, Jino K (2024). "Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation". Chemical & Pharmaceutical Bulletin. 72 (7): 610–617. doi:10.1248/cpb.c23-00416. PMID   38945937.
  2. 1 2 3 4 "Intra-Cellular Therapies". AdisInsight. 29 January 2025. Retrieved 26 February 2025.
  3. 1 2 3 "Delving into the Latest Updates on ITI-1284 with Synapse". Synapse. 20 February 2025. Retrieved 26 February 2025.
  4. ↑ "Proposed INN: List 132 International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). WHO Drug Information. 38 (4): 1073. 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.